Targeted breast ultrasound plays key role in evaluating breast abnormalities in women younger than 40

Nov 22, 2010

Targeted breast ultrasound should be the primary imaging technique used to evaluate focal (confined) breast signs and symptoms in women younger than 30, according to a study in the December issue of the American Journal of Roentgenology.

Breast ultrasound is commonly used to help diagnose breast abnormalities and to characterize potential abnormalities seen on . For women younger than 30 years with focal breast signs or symptoms, targeted ultrasound is the technique typically recommended for initial imaging evaluation. However, questions remain regarding the accuracy of ultrasound and the need for concurrent mammography in this patient population.

Researchers identified and reviewed all ultrasound examinations from January 1, 2002, through August 30, 2006, performed for focal breast signs or symptoms in women younger than 30 years at Seattle Alliance in Seattle, WA. Outcomes were determined by , 24 months of ultrasound surveillance or linkage with the regional tumor registry.

"The overall incidence of breast in our study was 0.4 percent," said Wendy B. DeMartini, MD, lead author of the study. "The sensitivity of ultrasound in detecting breast malignancy in our study was 100 percent, because all cancers were sonographically identified. Thus, there were no false-negative exams for which the addition of mammography would have added diagnostic value. Our negative predictive value (NPV) was 100 percent," said DeMartini.

"The high sensitivity and NPV of ultrasound in our investigation substantiates its application as the primary imaging technique in young women with focal breast concerns," she said.

Explore further: Two studies identify a detectable, pre-cancerous state in the blood

More information: www.ajronline.org

Provided by American College of Radiology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Gene test aids cancer profile

17 hours ago

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.